Natixis Loomis Sayles Focused Growth ETF seeks long-term growth of capital. Under normal market conditions, the fund will invest primarily in exchange-traded U.S.-listed common stocks and other exchange-traded equity securities. Exchange-traded equity securities may include, for example, other exchange-traded funds ("ETFs"), exchange-traded notes, exchange-traded preferred stocks, and exchange-traded real estate investment trusts ("REITs"). The fund normally invests across a wide range of sectors and industries. The fund is non-diversified.

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.

Reliance Global Group, Inc. is a diversified company, which engages in the business of insurance market and other relates sectors. It focuses on acquisition strategy, wholesale, and retail insurance agencies. The company was founded on August 2, 2013 and is headquartered in Lakewood, NJ.

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.

Comtech Telecommunications Corp. engages in the provision of emergency systems and wireless and satellite communications. It operates through Satellite and Space Communications and Terrestrial and Wireless Networks segments. The Satellite and Space Communication segment offers satellite ground station technologies, services and system integration that facilitate the transmission of voice, video, and data over GEO, MEO, and LEO satellite constellations, including solid-state and traveling wave tube power amplifiers, modems, VSAT platforms and frequency converters. The Terrestrial and Wireless Networks segment provides SMS Text to 911 services, providing alternate paths for individuals who need to request assistance method to reach Public Safety Answering Points. The company was founded in 1967 and is headquartered in Chandler, AZ.

Cambria Value and Momentum ETF seeks income and capital appreciation from investments in the U.S. equity market. The fund will seek to achieve its investment objective by investing, under normal market conditions, at least 80% of the value of the fund's net assets in U.S. exchange-listed equity securities. It may hedge up to 100% of the value of the fund's long portfolio. The fund may invest in securities of companies in any industry, but will limit the maximum allocation to any particular sector to 25%. It may invest up to 20% of the value of its net assets in U.S. dollar and non-U.S. dollar denominated money market instruments or other high quality debt securities, or ETFs.

La Rosa Holdings Corp. operates as a holding company, which provides real estate brokerage services. It sells technology-based products and services primarily to sales agents and the sales agents associated with its franchisees. The company operates through the five reportable segments: Residential Real Estate Brokerage Services, Franchising Services, Coaching Services, Property Management, and Commercial Real Estate Brokerage Services. The Residential Real Estate Brokerage Services segment engages in the real estate brokerage business. The Franchising Services segment engages in the franchising of real estate brokerage agencies. The Coaching Services segment engages in the delivery of coaching services to its brokers and franchisee's brokers. The Property Management segment engages in the training of its sales agents to provide residential property management services to owners of single family residential properties. The Commercial Real Estate Brokerage Services segment engages in the brokering of the sale of commercial real estate. La Rosa Holdings was founded by Joseph La Rosa in 2004 and is headquartered in Celebration, FL.